SEOM-TTCC clinical guideline in nasopharynx cancer (2021)

Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy (RT) is the cornerstone of locoregional treatment of non-disseminated disease and the association of chemotherapy improves...

Descripción completa

Detalles Bibliográficos
Autores principales: Rueda Domínguez, Antonio, Cirauqui, Beatriz, García Castaño, Almudena, Alvarez Cabellos, Ruth, Carral Maseda, Alberto, Castelo Fernández, Beatriz, Iglesias Rey, Leticia, Rubió-Casadevall, Jordi, Arrazubi, Virginia, Mesía, Ricard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Clinical Guides in Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986714/
https://www.ncbi.nlm.nih.gov/pubmed/35303267
http://dx.doi.org/10.1007/s12094-022-02814-x
Descripción
Sumario:Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy (RT) is the cornerstone of locoregional treatment of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.

Ejemplares similares